Liquidia Corporation (LQDA)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqCMUnited StatesUS53635D2027
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Liquidia Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:14. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 10 Nov 2026 06:00 | 0.98 | 1.22 | +25.3% | Beat |
| 12 Aug 2026 06:00 | 0.85 | 0.74 | -13.2% | Miss |
| 11 May 2026 06:00 | 0.40 | 0.52 | +29.2% | Beat |
| 05 Mar 2026 06:00 | 0.33 | 0.15 | -55.1% | Miss |
| 03 Nov 2025 06:00 | -0.35 | -0.04 | +88.7% | Beat |
| 12 Aug 2025 06:00 | -0.39 | -0.49 | -24.8% | Miss |
| 08 May 2025 06:00 | -0.42 | -0.45 | -7.1% | Miss |
| 19 Mar 2025 06:00 | -0.39 | -0.45 | -13.9% | Miss |
| 13 Nov 2024 06:00 | -0.40 | -0.39 | +2.2% | Beat |
| 07 Aug 2024 07:00 | -0.33 | -0.37 | -12.1% | Miss |
| 13 May 2024 17:00 | -0.28 | -0.39 | -37.0% | Miss |
| 13 Mar 2024 07:00 | -0.23 | -0.42 | -78.7% | Miss |
| 07 Nov 2023 06:00 | -0.19 | -0.24 | -26.3% | Miss |
| 10 Aug 2023 06:00 | -0.16 | -0.36 | -125.0% | Miss |
| 04 May 2023 16:00 | -0.17 | -0.15 | +16.6% | Beat |
| 16 Mar 2023 06:00 | -0.17 | -0.09 | +46.0% | Beat |
| 08 Nov 2022 16:00 | -0.19 | -0.14 | +26.3% | Beat |
| 11 Aug 2022 16:00 | -0.22 | -0.15 | +31.8% | Beat |
| 12 May 2022 16:00 | -0.20 | -0.28 | -42.5% | Miss |
| 17 Mar 2022 07:00 | -0.13 | -0.23 | -81.6% | Miss |
| 03 Nov 2021 16:00 | -0.15 | -0.14 | +6.7% | Beat |
| 10 Aug 2021 16:00 | -0.16 | -0.13 | +18.8% | Beat |
| 13 May 2021 07:00 | -0.27 | -0.21 | +22.2% | Beat |
| 22 Mar 2021 23:00 | -0.36 | -0.38 | -5.6% | Miss |
| 06 Nov 2020 16:00 | -0.36 | -0.40 | -11.1% | Miss |
| 10 Aug 2020 07:00 | -0.48 | -0.49 | -2.1% | Miss |
| 11 May 2020 16:00 | -0.55 | -0.52 | +5.5% | Beat |
| 11 Mar 2020 07:00 | -0.72 | -0.72 | 0.0% | In line |
| 13 Nov 2019 17:00 | -0.72 | -0.72 | 0.0% | In line |
| 08 Aug 2019 07:00 | -0.72 | -0.31 | +57.2% | Beat |
| 02 May 2019 10:00 | -0.58 | -0.87 | -50.0% | Miss |
| 26 Feb 2019 07:00 | -0.61 | -0.63 | -1.8% | Miss |
| 31 Oct 2018 07:00 | -0.58 | -0.62 | -7.8% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 158.3M | +1,031.2% | -68.9M | -43.5% | -0.80 | +51.8% | -42M |
| 2024 | 14M | -20.0% | -128.3M | -916.6% | -1.66 | -37.2% | -101.9M |
| 2023 | 17.5M | +9.7% | -78.5M | -448.9% | -1.21 | -80.6% | -52.9M |
| 2022 | 15.9M | — | -41M | -257.4% | -0.67 | — | -29.2M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 13 Nov 2026 In progress | 45.70 | 58.74 | 45.08 | 58.24 | +31.16% | 12,239,442 | |
| 02 Nov 2026 – 06 Nov 2026 | 45.71 | 51.11 | 41.52 | 44.40 | -1.46% | 13,194,100 | |
| 26 Oct 2026 – 30 Oct 2026 | 42.77 | 47.20 | 42.12 | 45.06 | +5.65% | 14,289,800 | |
| 19 Oct 2026 – 23 Oct 2026 | 34.42 | 42.83 | 33.65 | 42.65 | +24.16% | 18,230,700 | |
| 12 Oct 2026 – 16 Oct 2026 | 29.27 | 38.64 | 26.13 | 34.35 | +25.46% | 44,978,200 | |
| 05 Oct 2026 – 09 Oct 2026 | 28.07 | 29.35 | 24.59 | 27.38 | -4.40% | 28,920,800 | |
| 28 Sep 2026 – 02 Oct 2026 | 68.05 | 74.74 | 22.31 | 28.64 | -58.15% | 55,660,400 | |
| 21 Sep 2026 – 25 Sep 2026 | 67.18 | 71.81 | 65.74 | 68.43 | +2.32% | 4,908,500 | |
| 14 Sep 2026 – 18 Sep 2026 | 66.79 | 70.81 | 62.86 | 66.88 | +0.21% | 8,720,900 | |
| 08 Sep 2026 – 11 Sep 2026 | 68.00 | 69.94 | 66.62 | 66.74 | -2.80% | 4,059,800 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- LQDA Q3 Earnings Beat Estimates on Robust Yutrepia Sales (opens in a new tab) Zacks · 11 Nov 2026 16:38
- LQDA Q3 Earnings Call Highlights Growth and Post-Settlement Outlook (opens in a new tab) Zacks · 11 Nov 2026 14:00
- 3 Insider Selling Stories; 3 Different Signals for Investors (opens in a new tab) MarketBeat · 11 Nov 2026 13:10
- Needham Maintains Buy on Liquidia, Raises Price Target to $66 (opens in a new tab) Benzinga · 11 Nov 2026 05:44
- Liquidia (LQDA) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 19:00
- Liquidia Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 10 Nov 2026 18:15
- BTIG Maintains Buy on Liquidia, Raises Price Target to $87 (opens in a new tab) Benzinga · 10 Nov 2026 13:56
- Liquidia Corporation (LQDA) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 13:01
- Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference (opens in a new tab) 10 Nov 2026 13:00
- Liquidia (NASDAQ:LQDA) Posts YUTREPIA Revenue Beat but EPS Miss and United Therapeutics Settlement (opens in a new tab) ChartMill · 10 Nov 2026 12:41
- Liquidia Corporation (LQDA) Q3 Earnings and Revenues Beat Estimates (opens in a new tab) Zacks · 10 Nov 2026 11:40
- Liquidia Corporation Reports Third Quarter 2026 Financial Results (opens in a new tab) 10 Nov 2026 11:30
- Liquidia Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 10 Nov 2026 10:41
- UPDATE: Liquidia Q3 Adj. EPS $1.71 Beats $0.96 Estimate, Sales $225.000M Beat $214.182M Estimate (Adj EPS Excludes Litigation Settlement) (opens in a new tab) Benzinga · 10 Nov 2026 10:30
- Liquidia Q3 EPS $(2.64) Misses $0.94 Estimate, Sales $225.300M Beat $214.182M Estimate (opens in a new tab) Benzinga · 10 Nov 2026 07:32
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 58.12 USD
- Market cap
- 5.2B
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow LQDA and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.